3.22
price up icon0.31%   0.01
after-market 시간 외 거래: 3.11 -0.11 -3.42%
loading
전일 마감가:
$3.21
열려 있는:
$3.19
하루 거래량:
479.69K
Relative Volume:
0.98
시가총액:
$389.66M
수익:
$34.16M
순이익/손실:
$-50.62M
주가수익비율:
-6.3386
EPS:
-0.508
순현금흐름:
$703.00K
1주 성능:
+0.63%
1개월 성능:
-9.04%
6개월 성능:
-32.78%
1년 성능:
-44.48%
1일 변동 폭
Value
$3.17
$3.26
1주일 범위
Value
$3.1002
$3.44
52주 변동 폭
Value
$3.1002
$6.5488

Omniab Inc Stock (OABI) Company Profile

Name
명칭
Omniab Inc
Name
전화
510-250-7800
Name
주소
5980 HORTON STREET, EMERYVILLE
Name
직원
106
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
OABI's Discussions on Twitter

OABI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
OABI
Omniab Inc
3.22 389.66M 34.16M -50.62M 703.00K -0.508
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Omniab Inc Stock (OABI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-29 개시 RBC Capital Mkts Outperform
2023-04-21 개시 The Benchmark Company Buy
2023-04-13 개시 Craig Hallum Buy
2023-02-22 개시 Cowen Outperform
2023-02-13 개시 H.C. Wainwright Buy
2022-12-20 개시 Truist Buy
2022-12-16 개시 Credit Suisse Outperform
2022-11-29 개시 SVB Leerink Outperform
2022-11-28 개시 Stifel Buy
모두보기

Omniab Inc 주식(OABI)의 최신 뉴스

pulisher
Feb 01, 2025

Court Place Advisors LLC Sells 77,445 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm - The Malaysian Reserve

Jan 31, 2025
pulisher
Jan 28, 2025

JPMorgan Chase & Co. Sells 16,670 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jan 28, 2025
pulisher
Jan 27, 2025

3 US Penny Stocks With Market Caps Over $300M To Watch - Yahoo Finance

Jan 27, 2025
pulisher
Jan 27, 2025

OmniAb Insider Ups Holding During Year - Yahoo Finance

Jan 27, 2025
pulisher
Jan 24, 2025

Have OmniAb Insiders Been Selling Stock? - Simply Wall St

Jan 24, 2025
pulisher
Jan 23, 2025

Insider Selling: OmniAb, Inc. (NASDAQ:OABI) CEO Sells 41,811 Shares of Stock - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Insider Selling: OmniAb, Inc. (NASDAQ:OABI) Insider Sells 25,489 Shares of Stock - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Omniab CEO Matthew Foehr sells $135,467 in stock By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 22, 2025

OmniAb, Inc. (NASDAQ:OABI) CFO Sells 15,526 Shares - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Omniab CEO Matthew Foehr sells $135,467 in stock - Investing.com India

Jan 22, 2025
pulisher
Jan 22, 2025

Omniab chief legal officer Charles Berkman sells shares worth $82,584 By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 22, 2025

Omniab CFO Kurt Gustafson sells shares worth $50,304 By Investing.com - Investing.com South Africa

Jan 22, 2025
pulisher
Jan 22, 2025

Omniab chief legal officer Charles Berkman sells shares worth $82,584 - Investing.com

Jan 22, 2025
pulisher
Jan 22, 2025

Omniab CFO Kurt Gustafson sells shares worth $50,304 - Investing.com

Jan 22, 2025
pulisher
Jan 17, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Barclays PLC - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Bought by Barclays PLC - Defense World

Jan 17, 2025
pulisher
Jan 13, 2025

OmniAb (NASDAQ:OABI) Hits New 52-Week Low – Here’s What Happened - Defense World

Jan 13, 2025
pulisher
Jan 12, 2025

OABI stock touches 52-week low at $3.43 amid market challenges - Investing.com Nigeria

Jan 12, 2025
pulisher
Jan 11, 2025

OmniAb (NASDAQ:OABI) Hits New 1-Year LowTime to Sell? - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

OmniAb Announces Publication of Scientific Paper on Heavy Chain- - GuruFocus.com

Jan 10, 2025
pulisher
Jan 10, 2025

FY2024 EPS Estimates for OmniAb Raised by Leerink Partnrs - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

FY2024 EPS Estimates for OmniAb Lifted by Leerink Partnrs - MarketBeat

Jan 09, 2025
pulisher
Jan 06, 2025

OmniAb Presents High-Throughput Single B-cell Screening xPlorati - GuruFocus.com

Jan 06, 2025
pulisher
Jan 05, 2025

OmniAb, Inc. (NASDAQ:OABI) Shares Sold by Jane Street Group LLC - Defense World

Jan 05, 2025
pulisher
Jan 02, 2025

Geode Capital Management LLC Lowers Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

Barclays PLC Increases Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Jan 02, 2025
pulisher
Dec 30, 2024

Why OmniAb, Inc. (OABI) Is One of the Best Biotech Penny Stocks to Invest in Now? - Insider Monkey

Dec 30, 2024
pulisher
Dec 30, 2024

US Penny Stocks To Watch In December 2024 - Simply Wall St

Dec 30, 2024
pulisher
Dec 29, 2024

OmniAb (NASDAQ:OABI) Stock Price Up 2.8% – Still a Buy? - Defense World

Dec 29, 2024
pulisher
Dec 28, 2024

State Street Corp Grows Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Dec 28, 2024
pulisher
Dec 27, 2024

OmniAb (NASDAQ:OABI) Shares Up 2.8%Here's What Happened - MarketBeat

Dec 27, 2024
pulisher
Dec 22, 2024

With 55% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns - Yahoo Finance

Dec 22, 2024
pulisher
Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $542,000 Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Dec 21, 2024
pulisher
Dec 19, 2024

Fmr LLC Acquires 13,324 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

First Trust Water ETF (NYSEARCA:FIW) Shares Acquired by Fmr LLC - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

OABI stock touches 52-week low at $3.55 amid market challenges - Investing.com

Dec 18, 2024
pulisher
Dec 16, 2024

OmniAb Unveils Revolutionary AI-Powered Antibody Discovery Platform, Launches Advanced OmniHub™ Portal - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Tharimmune Advances TH104 Clinical Program: Phase 2 Trial Set for 2025 After Positive Phase 1 Results - StockTitan

Dec 16, 2024
pulisher
Dec 15, 2024

OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth By Investing.com - Investing.com South Africa

Dec 15, 2024
pulisher
Dec 15, 2024

OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth - Investing.com India

Dec 15, 2024
pulisher
Dec 15, 2024

Charles Schwab Investment Management Inc. Increases Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World

Dec 15, 2024
pulisher
Dec 14, 2024

OmniAb (NASDAQ:OABI) Shares Down 5.5%Here's Why - MarketBeat

Dec 14, 2024
pulisher
Dec 10, 2024

OmniAb CFO Kurt Gustafson sells $98,587 in stock By Investing.com - Investing.com Nigeria

Dec 10, 2024
pulisher
Dec 10, 2024

OmniAb chief legal officer sells $33,130 in shares By Investing.com - Investing.com Nigeria

Dec 10, 2024
pulisher
Dec 10, 2024

omniAb CEO Matthew Foehr sells $56,308 in stock By Investing.com - Investing.com Canada

Dec 10, 2024
pulisher
Dec 10, 2024

omniAb CEO Matthew Foehr sells $56,308 in stock - Investing.com India

Dec 10, 2024

Omniab Inc (OABI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
자본화:     |  볼륨(24시간):